Online Medical Forum > Constipation: Wyeth and progenics receive approval from european commission for relistor for opioid-induced constipation in advanced illness patients

Help - Search - Members - Calendar

Full Version: Constipation: Wyeth and progenics receive approval from european commission for relistor for opioid-induced constipation in advanced illness patients

Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Constipation

alex

Jul 12 2008, 12:30 PM

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), announced that the companies have received marketing approval for RELISTOR™ (methylnaltrexone bromide) subcutaneous injection from the European Commission. (Source: Health News from Medical News Today)

View the full article

This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.